Recombinant multi-species RBP2/KDM5A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RBP2/KDM5A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the Jumonji, AT-rich interactive domain 1 (JARID1) histone demethylase protein family. The encoded protein plays a role in gene regulation through the histone code by specifically demethylating lysine 4 of histone H3. The encoded protein interacts with many other proteins, including retinoblastoma protein, and is implicated in the transcriptional regulation of Hox genes and cytokines. This gene may play a role in tumor progression. [provided by RefSeq, Aug 2013]
The Alternative Names of target: Histone demethylase JARID1A,JARID1A,Jarid1a,Jumonji/ARID domain-containing protein 1A,KDM5A,Kdm5a,Lysine-specific demethylase 5A,NEDEHC,RBBP-2,RBBP2,RBP2,Rbbp2,Retinoblastoma-binding protein 2 (RBBP-2),[histone H3]-trimethyl-L-lysine(4) demethylase 5A

Target products collectionGo to RBP2/KDM5A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T28052-Ag-1/ GM-Tg-hg-T28052-Ag-2 Human RBP2/KDM5A protein Human
GM-Tg-rg-T28052-Ag-1/ GM-Tg-rg-T28052-Ag-2 Rat RBP2/KDM5A protein Rat
GM-Tg-mg-T28052-Ag-1/ GM-Tg-mg-T28052-Ag-2 Mouse RBP2/KDM5A protein Mouse
GM-Tg-cynog-T28052-Ag-1/ GM-Tg-cynog-T28052-Ag-2 Cynomolgus/Rhesus macaque RBP2/KDM5A protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T28052-Ag-1/ GM-Tg-felg-T28052-Ag-2 Feline RBP2/KDM5A protein Feline
GM-Tg-cang-T28052-Ag-1/ GM-Tg-cang-T28052-Ag-2 Canine RBP2/KDM5A protein Canine
GM-Tg-bovg-T28052-Ag-1/ GM-Tg-bovg-T28052-Ag-2 Bovine RBP2/KDM5A protein Bovine
GM-Tg-equg-T28052-Ag-1/ GM-Tg-equg-T28052-Ag-2 Equine RBP2/KDM5A protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T28052-Ag-1/ GM-Tg-hg-T28052-Ag-2; GM-Tg-rg-T28052-Ag-1/ GM-Tg-rg-T28052-Ag-2;
GM-Tg-mg-T28052-Ag-1/ GM-Tg-mg-T28052-Ag-2; GM-Tg-cynog-T28052-Ag-1/ GM-Tg-cynog-T28052-Ag-2;
GM-Tg-felg-T28052-Ag-1/ GM-Tg-felg-T28052-Ag-2; GM-Tg-cang-T28052-Ag-1/ GM-Tg-cang-T28052-Ag-2;
GM-Tg-bovg-T28052-Ag-1/ GM-Tg-bovg-T28052-Ag-2; GM-Tg-equg-T28052-Ag-1/ GM-Tg-equg-T28052-Ag-2
Products Name RBP2/KDM5A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RBP2/KDM5A
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RBP2/KDM5A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.